Freenome: Lance Baldo 

Freenome has hired Lance Baldo as its chief medical officer. Baldo has more than 20 years of clinical, product development, and operational experience and will be responsible for overseeing all aspects of Freenome's clinical development, medical and scientific affairs, and quality and regulatory teams with an initial focus on expanding the firm's capabilities beyond colorectal cancer.

Most recently, Baldo served as CMO of Adaptive Biotechnologies. Prior to that he held numerous roles with the Roche Group and its affiliates, including as senior VP and head of US medical affairs at Genentech. He holds an MD from the University of Connecticut School of Medicine and a BA in biology from Johns Hopkins University.